AIRE-Pilot
Pilot Randomized Controlled Trial of the AIRE Comprehensive Respiratory Self-Care Intervention for Preventing Complications of Acute Respiratory Infections in Older Adults in Primary Care
Sponsor study identifier
interventional
40
1 country
1
Study Start
September 9, 2026
Actual (reported)Primary Completion
October 20, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Acute respiratory infections are common reasons for seeking primary care. Most people recover at home, but some older adults may develop respiratory complications or worsening of long-term health conditions. Clear guidance about safe activity, breathing exercises, symptom monitoring, and when to seek further care may support recovery. The goal of this pilot clinical trial is to assess whether the AIRE respiratory self-care intervention and the planned study procedures can be carried out successfully in adults aged 60 to 80 years who receive care for an acute respiratory infection in a primary care center. The pilot will inform the procedures for a larger randomized clinical trial designed to evaluate whether AIRE can prevent complications. The main questions this pilot study aims to answer are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 31, 2026
Actual (reported)August 25, 2026
Actual (reported)September 9, 2026
Actual (reported)October 20, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Participant Recruitment Rate
The proportion of eligible individuals who provide informed consent and are enrolled in the study. The recruitment rate will be calculated as the number of participants enrolled divided by the total number of eligible individuals invited to participate, multiplied by 100. The number of individuals screened, eligible, invited, and enrolled will be recorded. Reasons for exclusion, refusal, or non-enrollment will also be documented and summarized by category.
Baseline
Completion of 14-Day Follow-Up
The proportion of enrolled participants who complete the final study assessment on day 14. A participant will be considered to have completed follow-up if information on symptoms, healthcare use, and possible respiratory complications is available through the day 14 telephone assessment or clinical record review. The measure will be reported as the number of participants who complete follow-up divided by the total number enrolled, multiplied by 100.
From enrollment to 14 days after enrollment
Completion of the Daily Self-Report Diary
The proportion of expected daily self-report diary entries completed by participants during the 14-day follow-up period. The diary records symptoms, daily activity, ability to perform usual activities, healthcare use, and, for participants assigned to AIRE, performance of breathing exercises. Completion will be calculated as the number of diary entries submitted divided by the total number of expected entries, multiplied by 100.
Adherence to AIRE Breathing Exercises
Daily, from enrollment through day 10 after enrollment
Incidence of Respiratory Complications Within 14 Days
From enrollment to 14 days after enrollment
Successful Completion of Scheduled Telephone Contacts
From enrollment to 14 days after enrollment
Successful Delivery of the AIRE Intervention
Day 1
Duration of the Initial AIRE Intervention Session
Day 1
Frequency of Operational Problems During Study Implementation
From participant screening to 14 days after enrollment
Acceptability of the AIRE Intervention
From the initial intervention session to 14 days after enrollment
Participants assigned to this arm will receive the AIRE intervention in addition to usual care for acute respiratory infections. The intervention includes respiratory self-care education, guidance to support safe recovery at home, and breathing exercise instruction. Participants will complete the same follow-up and outcome assessments as the control group.
Participants assigned to this arm will receive usual care for acute respiratory infections according to standard practice at the primary care center, without the AIRE self-care education or breathing exercise instruction. They will undergo the same study follow-up and outcome assessments as participants in the experimental group.
AIRE is a multicomponent respiratory self-care intervention delivered individually by a trained respiratory physical therapist. Participants receive a structured education session lasting approximately 10 minutes. The session covers hydration, warning signs, safe daily activity, and recommendations to avoid prolonged bed rest during recovery. Participants are taught breathing control followed by slow exhalation through pursed lips. Each breathing exercise session lasts approximately 5 to 10 minutes and is performed twice daily for 5 to 10 consecutive days, according to symptoms and tolerance. Participants are advised to stop the exercises if they experience dizziness, marked shortness of breath, chest pain, or worsening symptoms. Printed or audiovisual materials reinforce the recommendations and exercise instructions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
CESFAM Dr. Agustín Cruz Melo
Santiago, Santiago Metropolitan, 8320000, Chile
First Submitted
July 31, 2026
First Posted
August 25, 2026
Study Start
September 9, 2026
Actual (reported)Daily, from enrollment to 14 days after enrollment
Contact the study team to confirm eligibility.
Primary Completion
October 20, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 22, 2026
Record last verified: 2026-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: